Cargando…
Author Correction: Liposomal delivery of azithromycin enhances its immunotherapeutic efficacy and reduces toxicity in myocardial infarction
Autores principales: | Al‑Darraji, Ahmed, Donahue, Renée R., Tripathi, Himi, Peng, Hsuan, Levitan, Bryana M., Chelvarajan, Lakshman, Haydar, Dalia, Gao, Erhe, Henson, David, Gensel, John C., Feola, David J., Venditto, Vincent J., Abdel‑Latif, Ahmed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7969597/ https://www.ncbi.nlm.nih.gov/pubmed/33731792 http://dx.doi.org/10.1038/s41598-021-85720-6 |
Ejemplares similares
-
Liposomal delivery of azithromycin enhances its immunotherapeutic efficacy and reduces toxicity in myocardial infarction
por: Al-Darraji, Ahmed, et al.
Publicado: (2020) -
Azithromycin therapy reduces cardiac inflammation and mitigates adverse cardiac remodeling after myocardial infarction: Potential therapeutic targets in ischemic heart disease
por: Al-Darraji, Ahmed, et al.
Publicado: (2018) -
Immunomodulatory Effects of Azithromycin Revisited: Potential Applications to COVID-19
por: Venditto, Vincent J., et al.
Publicado: (2021) -
Gelatin coating enhances therapeutic cell adhesion to the infarcted myocardium via ECM binding
por: Davis, Kara A., et al.
Publicado: (2022) -
Rad GTPase Deletion Attenuates Post-Ischemic Cardiac Dysfunction and Remodeling
por: Manning, Janet R., et al.
Publicado: (2018)